Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 121

1.

Characteristic imaging features of desmoplastic small round cell tumour.

Arora VC, Price AP, Fleming S, Sohn MJ, Magnan H, LaQuaglia MP, Abramson S.

Pediatr Radiol. 2013 Jan;43(1):93-102. doi: 10.1007/s00247-012-2485-0. Epub 2012 Nov 23.

PMID:
23179482
[PubMed - indexed for MEDLINE]
2.

CT, MRI, and FDG-PET/CT imaging findings of abdominopelvic desmoplastic small round cell tumors: correlation with histopathologic findings.

Zhang WD, Li CX, Liu QY, Hu YY, Cao Y, Huang JH.

Eur J Radiol. 2011 Nov;80(2):269-73. doi: 10.1016/j.ejrad.2010.06.046. Epub 2010 Jul 21.

PMID:
20650589
[PubMed - indexed for MEDLINE]
3.

Positron emission tomography for response assessment in desmoplastic small round cell tumor.

Magnan H, Abramson SJ, Price AP, Grewal RK, Merchant MS, LaQuaglia MP, Meyers PA.

J Pediatr Hematol Oncol. 2013 Jul;35(5):e190-3. doi: 10.1097/MPH.0b013e3182707d4c.

PMID:
23073043
[PubMed - indexed for MEDLINE]
4.

Imaging of desmoplastic small round cell tumour in adults.

Kis B, O'Regan KN, Agoston A, Javery O, Jagannathan J, Ramaiya NH.

Br J Radiol. 2012 Feb;85(1010):187-92. doi: 10.1259/bjr/57186741. Epub 2011 Nov 29. Review.

PMID:
22128126
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.

Kanzaki R, Higashiyama M, Maeda J, Okami J, Hosoki T, Hasegawa Y, Takami M, Kodama K.

Interact Cardiovasc Thorac Surg. 2010 Jun;10(6):1009-14. doi: 10.1510/icvts.2009.227538. Epub 2010 Mar 2.

PMID:
20197344
[PubMed - indexed for MEDLINE]
Free Article
6.

Imaging of oncologic patients: benefit of combined CT and FDG PET in the diagnosis of malignancy.

Eubank WB, Mankoff DA, Schmiedl UP, Winter TC 3rd, Fisher ER, Olshen AB, Graham MM, Eary JF.

AJR Am J Roentgenol. 1998 Oct;171(4):1103-10.

PMID:
9763005
[PubMed - indexed for MEDLINE]
7.

High incidence of peritoneal implants in recurrence of intra-abdominal cancer revealed by 18F-FDG PET/CT in patients with increased tumor markers and negative findings on conventional imaging.

Panagiotidis E, Datseris IE, Exarhos D, Skilakaki M, Skoura E, Bamias A.

Nucl Med Commun. 2012 Apr;33(4):431-8. doi: 10.1097/MNM.0b013e3283506ae1.

PMID:
22293498
[PubMed - indexed for MEDLINE]
8.

Is combined 18F-fluorodeoxyglucose-positron emission tomography/computed tomography superior to positron emission tomography or computed tomography alone for diagnosis, staging and restaging of pancreatic lesions?

Casneuf V, Delrue L, Kelles A, Van Damme N, Van Huysse J, Berrevoet F, De Vos M, Duyck P, Peeters M.

Acta Gastroenterol Belg. 2007 Oct-Dec;70(4):331-8.

PMID:
18330088
[PubMed - indexed for MEDLINE]
9.

Clinical utility of F-18 FDG PET/CT in recurrent breast carcinoma.

Manohar K, Mittal BR, Senthil R, Kashyap R, Bhattacharya A, Singh G.

Nucl Med Commun. 2012 Jun;33(6):591-6. doi: 10.1097/MNM.0b013e3283516716.

PMID:
22334135
[PubMed - indexed for MEDLINE]
10.

(18) F-fluorodeoxyglucose positron emission tomography/computed tomography for the detection of recurrent bone and soft tissue sarcoma.

Al-Ibraheem A, Buck AK, Benz MR, Rudert M, Beer AJ, Mansour A, Pomykala KL, Haller B, Juenger H, Scheidhauer K, Schwaiger M, Herrmann K.

Cancer. 2013 Mar 15;119(6):1227-34. doi: 10.1002/cncr.27866. Epub 2012 Dec 11.

PMID:
23233156
[PubMed - indexed for MEDLINE]
Free Article
11.
12.

A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.

Kauhanen SP, Komar G, Seppänen MP, Dean KI, Minn HR, Kajander SA, Rinta-Kiikka I, Alanen K, Borra RJ, Puolakkainen PA, Nuutila P, Ovaska JT.

Ann Surg. 2009 Dec;250(6):957-63. doi: 10.1097/SLA.0b013e3181b2fafa.

PMID:
19687736
[PubMed - indexed for MEDLINE]
13.

Preoperative staging of non-small-cell lung cancer: comparison of whole-body diffusion-weighted magnetic resonance imaging and 18F-fluorodeoxyglucose-positron emission tomography/computed tomography.

Sommer G, Wiese M, Winter L, Lenz C, Klarhöfer M, Forrer F, Lardinois D, Bremerich J.

Eur Radiol. 2012 Dec;22(12):2859-67. doi: 10.1007/s00330-012-2542-y. Epub 2012 Jul 9.

PMID:
22772365
[PubMed - indexed for MEDLINE]
14.

Impact of F18-fluorodeoxyglycose positron emission tomography/computed tomography on the management of resectable pancreatic tumours.

Yao J, Gan G, Farlow D, Laurence JM, Hollands M, Richardson A, Pleass HC, Lam VW.

ANZ J Surg. 2012 Mar;82(3):140-4. doi: 10.1111/j.1445-2197.2011.05972.x. Epub 2012 Jan 17.

PMID:
22510123
[PubMed - indexed for MEDLINE]
15.

[F-18]fluorodeoxyglucose positron emission tomography and positron emission tomography: computed tomography in recurrent and metastatic cholangiocarcinoma.

Jadvar H, Henderson RW, Conti PS.

J Comput Assist Tomogr. 2007 Mar-Apr;31(2):223-8.

PMID:
17414758
[PubMed - indexed for MEDLINE]
16.

Accuracy of whole-body dual-modality fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography (FDG-PET/CT) for tumor staging in solid tumors: comparison with CT and PET.

Antoch G, Saoudi N, Kuehl H, Dahmen G, Mueller SP, Beyer T, Bockisch A, Debatin JF, Freudenberg LS.

J Clin Oncol. 2004 Nov 1;22(21):4357-68.

PMID:
15514377
[PubMed - indexed for MEDLINE]
Free Article
17.

Comparison of the diagnostic value of FDG-PET/CT and axillary ultrasound for the detection of lymph node metastases in breast cancer patients.

Riegger C, Koeninger A, Hartung V, Otterbach F, Kimmig R, Forsting M, Bockisch A, Antoch G, Heusner TA.

Acta Radiol. 2012 Dec 1;53(10):1092-8. doi: 10.1258/ar.2012.110635. Epub 2012 Sep 22.

PMID:
23002144
[PubMed - indexed for MEDLINE]
18.

Whole-body FDG positron emission tomographic imaging for staging esophageal cancer comparison with computed tomography.

Meltzer CC, Luketich JD, Friedman D, Charron M, Strollo D, Meehan M, Urso GK, Dachille MA, Townsend DW.

Clin Nucl Med. 2000 Nov;25(11):882-7.

PMID:
11079584
[PubMed - indexed for MEDLINE]
19.

18F-FDG PET/CT as a staging procedure in primary stage II and III breast cancer: comparison with conventional imaging techniques.

Koolen BB, Vrancken Peeters MJ, Aukema TS, Vogel WV, Oldenburg HS, van der Hage JA, Hoefnagel CA, Stokkel MP, Loo CE, Rodenhuis S, Rutgers EJ, Valdés Olmos RA.

Breast Cancer Res Treat. 2012 Jan;131(1):117-26. doi: 10.1007/s10549-011-1767-9. Epub 2011 Sep 21.

PMID:
21935602
[PubMed - indexed for MEDLINE]
20.

Whole-body FDG PET/CT is more accurate than conventional imaging for staging primary breast cancer patients.

Riegger C, Herrmann J, Nagarajah J, Hecktor J, Kuemmel S, Otterbach F, Hahn S, Bockisch A, Lauenstein T, Antoch G, Heusner TA.

Eur J Nucl Med Mol Imaging. 2012 May;39(5):852-63. doi: 10.1007/s00259-012-2077-0. Epub 2012 Mar 6.

PMID:
22392069
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk